S Roger Keith (23 results)

Soft cover. Condition: Very Good-. David Mattingly; (illustrator). 1st Edition. Light edge and corner wear with faint creasing on the spine and some rubbing on the covers; no interior markings. Wraparound cover art by David Mattingly. This anthology contains: A Scientific History of Vampirism by Greg Cox; Pillar of Fire by Ray Bradbury; And Not Quite Human by Joe L. Hensley; The Man Who Loved the Vampire Lady by Brian Stableford; Born Again by S. N. Dyer; Kaeti's Nights by Keith Roberts; Pyotr's Story by Spider Robinson; Vanishing Breed by Leslie Roy Carter; Fleas by Dean Ing; Leechcraft by Susan Petrey; Shambleau by C. L. Moore; The Stainless Steel Leech by Roger Zelazny; and An Anthropological Approach to Vampirism by T. K. F. Weisskopf. Book.

Soft cover. Condition: Very Good. David Mattingly; (illustrator). First Soft Cover Edition. (xii) 274 pp. Light edge and corner wear with some minor creasing on the spine and a few small marks on the front cover; no interior markings. Cover art by David Mattingly. This anthology contains: Born Again by Sharon N. Farber writing as S. N. Dyer; Shambleau by C. L. Moore; The Stainless Steel Leech by Roger Zelazny; Pillar of Fire by Ray Bradbury; And Not Quite Human by Joe L. Hensley; The Man Who Loved the Vampire Lady by Brian Stableford; Kaeti's Nights by Keith Roberts; Pyotr's Story by Spider Robinson; Vanishing Breed by Leslie Roy Carter; Fleas by Dean Ing; and Leechcraft by Susan Petrey. Book.

Soft cover. Condition: Very Good. Wendi Pini; Freff; Stephen Fabian; (illustrator). First Edition. 176 pp. Digest format. Volume 22, number 7. Light edge and corner wear with a crease on the spine. Cover art by Wendi Pini; interiors by: Freff; and Stephen Fabian. This issue contains: A Knight of Ghosts and Shadows (part 1 of 2) by Poul Anderson; Mephisto and the Ion Explorer by Colin Kapp; Such is Fate by Arsen Darnay; Julie by Jan Trenholm; Egantei and the Sage by John C. White; Saying Goodbye by Scott Edelstein; and Death and Taxes by S. Roger Keith; along with the usual features, including a letter from Fred Saberhagen. Size: 12mo. Book.

Soft cover. Condition: Very Good. Kelly Freas; (illustrator). First Edition. 253 pp. Ace Book A12. Lightly rubbed on the corners with a faint crease on the spine. Cover art and interior line drawings by Kelly Freas. This anthology contains: Divine Madness by Roger Zelazny; The Lost Leonardo by J. G. Ballard; Narrow Valley by R. A. Lafferty; Come Lady Death by Peter S. Beagle; Break the Door of Hell - a novelette by John Brunner; The Immortal by Jorge Luis Borges; Comet Wine - a novelette by Ray Russell; The Other by Katherine MacLean; A Red Heart and Blue Roses by Mildred Clingerman; The Squirrel Cage by Thomas M. Disch; Nackles by Curt Clark; Timothy by Keith Roberts; Basilisk by Avram Davidson; The Evil Eye - a novelette by Alfred Gillespie; and Stanley Toothbrush by Terry Carr. Book.

Paperback. Condition: Good. Cover By Gray Morrow (illustrator). A little reading wear, binding solid; good to very good overall. Contains: Clear as Mud (Laumer), The Winged Helmet (saberhagen), Faust Aleph-Null (Blish - serial), The Felled Star (Farmer- serial), The Trouble with Vegans (Deeley), Paint 'em Green (Filer). Book.

Soft cover. Condition: Very Good. 257pp. Articles on journeyman millwrights; 'Lyons v. Wilkins'; 'British Association of Colliery Management'; Caterpillar Tractors; UNITE amalgamation; European social models and UK; two articles on NUPE.

Tapa Blanda. Condition: Muy bien. 1ª Edición. Tennessee Williams, V. S. Prichett, Frederic Morton, Günter Grass, Roger Price, Dan Greenburg and John Gregory Dunne, Alan Watts, D. Keith Mano, EXCELENTE ejemplar. 468pp.

Condition: New. Satisfaction Guaranteed or your money back.

hardcover. Condition: New. In shrink wrap. Looks like an interesting title!

Encuadernación de tapa blanda. Condition: Nuevo. BUSBY, K. / R. DALRYMPLE, EDS.: ARTHURIAN LITERATURE, 20. CAMBRIDGE, 2003, vii 206 p. , 645 gr. Encuadernacion original. Nuevo. (NB-8-1) 645 gr. Libro.

Condition: New. In.

Condition: New.

Condition: New.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume is the first-ever complete treatise on polymyxins and presents the most comprehensive and up-to-date reviews of all major research and clinical topics from chemistry, microbiology, pharmacology, clinical use, to drug discovery. All chapters were written by internationally leading researchers and clinicians in the field.It is our wish that readers discover the importance of polymyxin structure in relation to the mechanisms of activity, resistance and toxicity. We emphasized that reliable analytic methods for polymyxins are critical when investigating their pharmacokinetics (PK) and pharmacodynamics (PD). The complicated dose definitions and different pharmacopoeial standards have already compromised the safe use of polymyxins in patients. Therefore, informed by the latest pharmacological information, scientifically-based dosing recommendations have been proposed for intravenous polymyxins. Considering the PK/PD limitations and potential development of resistance, polymyxin combinations are encouraged; however, the current literature has not shown definite microbiological benefits, possibly because most clinical studies to date overlooked key PK/PD principles. Nephrotoxicity is the major dose-limiting factor and it is imperative to elucidate the mechanisms and develop novel approaches to minimize polymyxin-associated toxicities. In addition, the anti-endotoxin effect of polymyxins supports their clinical use to treat Gram-negative sepsis. Fortunately, the discovery of new-generation polymyxins with wider therapeutic windows has benefited from the latest achievements in polymyxin research.This book provides extensive pharmacological information on polymyxins to infectious diseases clinicians, pharmacists, clinical microbiologists, antimicrobial pharmacologists, and pharmaceutical scientists, and is an essential read for those who aim to develop novel polymyxins and improve their clinical use as a last-line defense against Gram-negative 'superbugs'.

Hardcover. Condition: Brand New. 376 pages. 10.00x7.00x1.06 inches. In Stock.

Condition: New.

Hardcover. Condition: New.

Condition: new. Questo è un articolo print on demand.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides a comprehensive review on pharmacokinetics, pharmacodynamics and toxicity of polymyxins&nbspClarifies the confusing definitions of potency of colistin used in different parts of the worldRev.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume is the first-ever complete treatise on polymyxins and presents the most comprehensive and up-to-date reviews of all major research and clinical topics from chemistry, microbiology, pharmacology, clinical use, to drug discovery. All chapters were written by internationally leading researchers and clinicians in the field.It is our wish that readers discover the importance of polymyxin structure in relation to the mechanisms of activity, resistance and toxicity. We emphasized that reliable analytic methods for polymyxins are critical when investigating their pharmacokinetics (PK) and pharmacodynamics (PD). The complicated dose definitions and different pharmacopoeial standards have already compromised the safe use of polymyxins in patients. Therefore, informed by the latest pharmacological information, scientifically-based dosing recommendations have been proposed for intravenous polymyxins. Considering the PK/PD limitations and potential development of resistance, polymyxin combinations are encouraged; however, the current literature has not shown definite microbiological benefits, possibly because most clinical studies to date overlooked key PK/PD principles. Nephrotoxicity is the major dose-limiting factor and it is imperative to elucidate the mechanisms and develop novel approaches to minimize polymyxin-associated toxicities. In addition, the anti-endotoxin effect of polymyxins supports their clinical use to treat Gram-negative sepsis. Fortunately, the discovery of new-generation polymyxins with wider therapeutic windows has benefited from the latest achievements in polymyxin research.This book provides extensive pharmacological information on polymyxins to infectious diseases clinicians, pharmacists, clinical microbiologists, antimicrobial pharmacologists, and pharmaceutical scientists, and is an essential read for those who aim to develop novel polymyxins and improve their clinical use as a last-line defense against Gram-negative 'superbugs'. 376 pp. Englisch.

Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume is the first-ever complete treatise on polymyxins and presents the most comprehensive and up-to-date reviews of all major research and clinical topics from chemistry, microbiology, pharmacology, clinical use, to drug discovery. All chapters were written by internationally leading researchers and clinicians in the field.It is our wish that readers discover the importance of polymyxin structure in relation to the mechanisms of activity, resistance and toxicity. We emphasized that reliable analytic methods for polymyxins are critical when investigating their pharmacokinetics (PK) and pharmacodynamics (PD). The complicated dose definitions and different pharmacopoeial standards have already compromised the safe use of polymyxins in patients. Therefore, informed by the latest pharmacological information, scientifically-based dosing recommendations have been proposed for intravenous polymyxins. Considering the PK/PD limitations and potential development of resistance, polymyxin combinations are encouraged; however, the current literature has not shown definite microbiological benefits, possibly because most clinical studies to date overlooked key PK/PD principles. Nephrotoxicity is the major dose-limiting factor and it is imperative to elucidate the mechanisms and develop novel approaches to minimize polymyxin-associated toxicities. In addition, the anti-endotoxin effect of polymyxins supports their clinical use to treat Gram-negative sepsis. Fortunately, the discovery of new-generation polymyxins with wider therapeutic windows has benefited from the latest achievements in polymyxin research.This book provides extensive pharmacological information on polymyxins to infectious diseases clinicians, pharmacists, clinical microbiologists, antimicrobial pharmacologists, and pharmaceutical scientists, and is an essential read for those who aim to develop novel polymyxins and improve their clinical use as a last-line defense against Gram-negative ¿superbugs¿.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 376 pp. Englisch.

Condition: New. Print on Demand.

Condition: New. PRINT ON DEMAND.